MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39376558

about

Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update microRNA regulation of Wnt signaling pathways in development and disease miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Novel microRNAs differentially expressed during aging in the mouse brain Prognostic role of microRNA-205 in multiple human malignant neoplasms: a meta-analysis of 17 studies Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart MiR-145 mediates zebrafish hepatic outgrowth through progranulin A signaling.NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging.miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity.MicroRNA regulation of mitogenic signaling networks in the human placenta.Identifying microRNAs involved in aging of the lateral wall of the cochlear duct MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.Regulation of IGF -1 signaling by microRNAs.Profile of cerebrospinal microRNAs in fibromyalgia.Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.Epigenetics of hepatocellular carcinoma: role of microRNA The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.miRNA in hepatocellular carcinoma.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.Targeting IGF1R pathway in cancer with microRNAs: How close are we ?Clinical implications of microRNAs in liver cancer stem cells.Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc.Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies.Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma.microRNA-145 downregulates SIP1-expression but differentially regulates proliferation, migration, invasion and Wnt signaling in SW480 and SW620 cells.

P2860

Q26766068-36FAEAEC-49DB-4647-B852-2C3423E82178 Q26783563-A5D7179C-8AFD-4B9E-97FF-636FCC87B6AB Q27003050-19413769-C2B1-4EA3-B611-2A346451AC95 Q27011654-3BB13C2D-9548-4BB3-BCAA-5F5743C30F37 Q27023295-8BCC263A-0951-462E-83DF-369EFA590C89 Q27335905-CA839072-9ABE-48A9-88DC-452C770A9990 Q28084872-D18746C2-B42A-49BE-83EA-A36350DC03EF Q28396541-05F387B6-E584-4752-92F3-D1E71F983F6C Q33713078-16CE15FC-928D-43EC-8ADE-F9829E4D6B94 Q33754800-C0FD96CE-DE31-4172-BD75-1F870BBF171C Q33802900-85C349A8-2394-449A-A44E-54BC70A0BCF9 Q34182483-48A5B05B-90DB-4743-B908-50E64FEF881C Q34371623-066A9C59-8D66-4473-AE69-DB30B33D0EA6 Q34430950-CB4EE849-B6D5-4E30-87D8-9C107ACAD9BA Q34535461-978E6E68-12FE-4A77-8D57-A82D18B979FC Q34571491-52D746DD-6193-40DB-8A80-70B392D6613A Q34936657-D3F2A3F2-D240-422A-8334-87EB772721D1 Q35036703-536D7FEA-6267-44EB-A890-BF38D2077010 Q35538436-D7D0A0A9-9B06-479D-A337-B1A0A585C053 Q35715931-CC58E48E-045A-4B3A-A226-A37E82F684C3 Q35826468-47A870B7-0F5F-4A36-900D-92528611E1F0 Q36959130-C762836A-D297-4B83-BDE1-3F9FD6DBF196 Q37173106-2775A3EE-C157-4570-904B-DCD56E5242EC Q38136179-DB3EB0CB-A883-44B3-89D2-6D744894507C Q38164571-D23C2D1A-D9D7-4CE6-AB88-2CAAC2D60586 Q38231531-5280B73D-00FA-457B-8E5A-DABACA401891 Q38568853-46019157-A0FD-4C9D-9A41-A31B502795C3 Q38970929-643A6BF5-9365-4D14-826C-146E2633BC79 Q39161179-C9EDACEE-E9C2-45D2-9349-E169B65E8294 Q39371841-14BE4BF1-D271-415A-81AE-05C1B29465AA Q39419867-E6D430D2-A679-493F-997B-798C2D34B199 Q39817084-7271F902-88A0-4304-B178-D0A3335B61D7 Q40555570-B1BC7A0A-1ED0-440E-A9B0-AFAAE097235D Q41322632-AA14F098-DBF5-40F7-B452-53926AF54085 Q41471395-4C42B734-1B09-4687-BFF9-E56D3787B76C Q43046143-9E769FA4-39FC-46AA-995B-C6AA19BCA71D Q43717784-A1697273-B306-468A-A126-69DBA9BF8435 Q47096853-72F71097-1008-4131-B3E6-7A65B40B95D5 Q47097555-F2E3FC66-03E9-4E2F-8A6B-E14EC5F4554B Q47916413-C7CDF748-F587-41BC-9B90-6CD9D79B72D1

P2860

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39376558

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@en

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@nl

type

label

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@en

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@nl

prefLabel

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@en

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@nl

P1433

Q39376558-7F31374A-7B52-4A41-B359-E0C2B12F870F

P1476

Q39376558-7B01F4A9-5CB4-4532-A7C5-4503F5E103FB

P2093

Q39376558-15157A97-F82B-4090-85CE-A76D45B26957

Q39376558-268CA918-23AD-4F13-994E-0F2D4AC78192

Q39376558-73A2DFD2-B155-405F-8135-DC29B2628680

Q39376558-785878A1-9BD8-4510-AF9E-C0F3299F60AA

Q39376558-CFAFF244-6286-4CAD-B62E-CE12DEADC7E2

Q39376558-DBF51935-AAE6-48E7-90EC-F2F0BAD8D1DC

P2860

Q39376558-059ED573-A1E7-4869-9ACA-670E18778C05

Q39376558-0C412008-15FA-4ACA-87B9-41773FD2DCC2

Q39376558-0F067A9E-7E35-41AB-B486-2A7DCC74D825

Q39376558-0F797A3B-58DE-449C-8DF3-F5C1643131B3

Q39376558-162EFB79-BA66-47E8-907A-1879BA516142

Q39376558-164D4BA0-1F3A-45F1-9DE0-746C504FD0C5

Q39376558-1D29BE4D-0EB6-4480-B4E7-4F17B77A7483

Q39376558-250ECDFD-53CB-40FD-AC29-25408FC44616

Q39376558-2D68F471-1E34-48DC-8325-E7D04086B033

Q39376558-3390A413-6F1F-487F-BE90-3B6960125FD6

P304

Q39376558-582415C6-FF01-442D-A062-67A7AC4D534E

P31

Q39376558-29909D83-EDB3-42CF-9ED4-3152DA06A71F

P356

Q39376558-03F71439-F59D-4B79-91DD-644CF09FC363

P407

Q39376558-963C7DA3-B471-4E2E-9218-D060E718FCDA

P433

Q39376558-0AE4C5C9-7B11-4847-B5B3-DE80DA2CAFCE

P478

Q39376558-B5CA3785-8DC7-4E8D-AFB7-EE3DC2B93B83

P50

Q39376558-219429AD-4907-4C5A-A69C-2BB1DBD31F87

P577

Q39376558-44C3D748-49A1-4C36-9116-AD88B6DEA6BC

P698

Q39376558-D6A85789-C882-4656-9254-C54E1148DCBB

P921

Q39376558-EE25F66F-3B94-4D77-BB56-8B393FFBCBEC

P356

P1433

P1476

MiR-145 modulates multiple com ...... y in hepatocellular carcinoma.

@en

P2093

Arthur K-K Ching

http://www.w3.org/2001/XMLSchema#string

Chun-Kwok Wong

http://www.w3.org/2001/XMLSchema#string

Ka-Fai To

http://www.w3.org/2001/XMLSchema#string

Nathalie Wong

http://www.w3.org/2001/XMLSchema#string

Priscilla T-Y Law

http://www.w3.org/2001/XMLSchema#string

Queenie W-L Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2

RAS is regulated by the let-7 microRNA family

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

MicroRNA gene expression deregulation in human breast cancer

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver

MicroRNA signatures in human ovarian cancer

P304

1134-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGS130

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Anthony Wing-Hung Chan

P577

2012-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22431718

http://www.w3.org/2001/XMLSchema#string

P921